News

Deal Announcements

Akonni Biosystems Banks New Venture Capital

Wednesday, December 9, 2015 5:28:00 AM PDT | VentureDeal
   Frederick, Maryland  --  Diagnostics technology company Akonni Biosystems has landed $619,000 in equity venture capital funding, according to an SEC regulatory filing.

Akonni has developed a product line of diagnostics for the accurate and early detection of human diseases and infectious agents.

The company's TruDiagnosis system enables testing for a variety of molecular markers associated with human diseases on a gel-drop micro-array platform.

Investors in the financing were not disclosed, nor was how the company intends to use the proceeds.

Akonni is still seeking $2.4 million in additional equity financing, according to the filing.

Minimum investment size per investor was listed as $25,000.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1